Satellos Bioscience Inc. MSLE
8.70
(0.01)
(0.11%)
as of 25 Sep
- Market cap
- $184.8M
- P/E
- 0.0×
Follow MSLE
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
17.54 | 4.77 | 0.22 | 1.81 | 0.42 | 2.59 | 0.79 | 11.13 | 14.16 | 7.77 |
Net Debt/EBITDA |
1.40 | 0.77 | 0.00 | 0.45 | 0.04 | 0.87 | 0.37 | 2.38 | 2.78 | 1.05 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.89 | 0.99 | 0.65 | 1.15 | 0.61 | 0.32 | 0.50 | 0.91 | 0.88 | 0.95 |
Capex/Depreciation |
(0.14) | 0.00 | (2.00) | (1.96) | 0.00 | 10.49 | 0.00 | (2.56) | 0.00 | (1.50) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (50.35%) | (73.81%) | (722.59%) | (14,680.40%) | 3,572.03% | (317.08%) | (159.00%) | (71.94%) | (53.39%) | (66.37%) | |
| (48.32%) | (65.54%) | (217.65%) | (235.05%) | (146.71%) | (236.78%) | (117.61%) | (62.64%) | (49.39%) | (60.20%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (64.98%) | (367.58%) | (955.67%) | 0.00% | (22,347.13%) |
Return on Tangible Assets |
(65.08%) | (113.81%) | 272.64% | (293.37%) | 198.38% | (463.27%) | 1,920.44% | (43.27%) | (43.75%) | (89.52%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.57 | 0.63 | 0.09 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(2.87) | (2.68) | (2.41) | (3.32) | (1.06) | (1.31) | (1.48) | (1.49) | (1.91) | (1.62) |
Cash per Share |
5.07 | 2.47 | 0.02 | 1.46 | 0.08 | 1.94 | 0.50 | 4.07 | 5.08 | 1.90 |
Shareholders Equity per Share |
4.97 | 2.38 | (1.36) | 0.98 | (0.87) | 4.17 | 0.87 | 4.19 | 4.93 | 1.90 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.97 | 2.38 | (1.36) | 0.98 | (0.87) | 4.17 | 0.87 | 4.19 | 4.93 | 1.90 |
Free Cash Flow |
(1.01) | (0.94) | (0.85) | (1.69) | (0.68) | (2.63) | (4.40) | (10.76) | (18.26) | (23.60) |
Working Capital |
1.73 | 0.84 | (0.48) | 0.49 | (0.56) | 2.66 | (0.46) | 27.19 | 47.16 | 27.78 |
Capital Expenditures |
0.00 | — | 0.00 | 0.00 | — | 1.39 | 0.00 | (0.01) | 0.00 | (0.01) |
Net Current Asset Value |
1.73 | 0.84 | (0.48) | 0.49 | (0.56) | 2.66 | (0.46) | 27.19 | 47.16 | 27.78 |
| Other line items | ||||||||||
Quick Ratio |
17.35 | 4.22 | 0.17 | 1.74 | 0.40 | 2.57 | 0.77 | 11.08 | 13.67 | 6.84 |
Depreciation/Fixed assets |
7.96 | 15.08 | 0.50 | 0.50 | 1.00 | 20.34 | 399.79 | 0.37 | 730.00 | 0.80 |
Cash ROIC |
(28.58%) | (55.18%) | 180.31% | (135.94%) | 132.78% | (32.84%) | (108.05%) | (18.09%) | (19.07%) | (42.53%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.86) | (2.68) | (2.40) | (3.31) | (1.06) | (2.00) | (1.48) | (1.49) | (1.91) | (1.62) |
Capex per Share |
(0.01) | 0.00 | (0.01) | (0.01) | 0.00 | 0.69 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.02 | 0.05 | 0.08 | 0.21 | 0.32 | 0.38 | 0.31 | 0.32 | 0.43 | 0.40 |
Average Payables |
0.09 | 0.16 | 0.42 | 0.61 | 0.79 | 1.32 | 1.93 | 2.43 | 3.13 | 3.84 |
Average Assets |
2.33 | 1.46 | 0.60 | 0.62 | 0.76 | 5.23 | 7.41 | 18.79 | 41.78 | 41.32 |
Average Common Equity |
2.23 | 1.29 | 0.18 | 0.01 | (0.03) | 3.90 | 5.48 | 16.36 | 38.65 | 37.47 |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates